---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009336"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T08:26:15.074675+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences regains Nasdaq bid price compliance

## Summary
- Received notice from Nasdaq on March 4, 2025 that it complied with Listing Rule 5550(a)(2).
- Compliance resolves potential delisting risk due to low stock price.
- Company's common stock continues trading on Nasdaq under symbol ENVB.

## SEC filing metadata
- accession: 0001493152-25-009336
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225009336/0001493152-25-009336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225009336/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009336
- JSON: https://secwatch.observer/filing/0001493152-25-009336.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.